These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26098994)

  • 1. In Vitro Determination of Respimat
    Bickmann D; Kamin W; Sharma A; Wachtel H; Moroni-Zentgraf P; Zielen S
    J Aerosol Med Pulm Drug Deliv; 2016 Feb; 29(1):76-85. PubMed ID: 26098994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and clinical characterization of the valved holding chamber AeroChamber Plus
    Wachtel H; Nagel M; Engel M; El Azzi G; Sharma A; Suggett J
    Respir Med; 2018 Apr; 137():181-190. PubMed ID: 29605203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old.
    Kamin W; Frank M; Kattenbeck S; Moroni-Zentgraf P; Wachtel H; Zielen S
    J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):372-81. PubMed ID: 25844687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of switching tiotropium HandiHaler® to Respimat® Soft Mist™ Inhaler in patients with COPD: the difference of adverse events and usability between inhaler devices.
    Asakura Y; Nishimura N; Maezawa K; Terajima T; Kizu J; Chohnabayashi N
    J Aerosol Med Pulm Drug Deliv; 2013 Feb; 26(1):41-5. PubMed ID: 22691112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: does inhaler choice matter?
    Dahl R; Kaplan A
    BMC Pulm Med; 2016 Oct; 16(1):135. PubMed ID: 27724909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro dose comparison of Respimat
    Ciciliani AM; Langguth P; Wachtel H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1565-1577. PubMed ID: 28603412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Respimat Soft Mist Inhaler using a concurrent CFD and in vitro approach.
    Worth Longest P; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):99-112. PubMed ID: 18956950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tiotropium Respimat(®) Versus HandiHaler(®): Comparison of Bronchodilator Efficacy of Various Doses in Clinical Trials.
    Calverley PM; Könen-Bergmann M; Richard F; Bell S; Hohlfeld JM
    Adv Ther; 2016 May; 33(5):786-93. PubMed ID: 27084728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, tolerability, and plasma exposure of tiotropium Respimat® in children and adults with cystic fibrosis.
    Konstan MW; Sharma A; Moroni-Zentgraf P; Wang F; Koker P
    J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):137-44. PubMed ID: 25380193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids.
    Vogelberg C; Moroni-Zentgraf P; Leonaviciute-Klimantaviciene M; Sigmund R; Hamelmann E; Engel M; Szefler S
    Respir Res; 2015 Feb; 16(1):20. PubMed ID: 25851298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).
    Hamilton M; Leggett R; Pang C; Charles S; Gillett B; Prime D
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):498-506. PubMed ID: 26372465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily tiotropium Respimat(®) 5 μg is an efficacious 24-h bronchodilator in adults with symptomatic asthma.
    Timmer W; Moroni-Zentgraf P; Cornelissen P; Unseld A; Pizzichini E; Buhl R
    Respir Med; 2015 Mar; 109(3):329-38. PubMed ID: 25661281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Respimat(®) Soft Mist™ Inhaler and its clinical utility in respiratory disorders.
    Dalby RN; Eicher J; Zierenberg B
    Med Devices (Auckl); 2011; 4():145-55. PubMed ID: 22915941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro characterization of the OptiChamber Diamond valved holding chamber.
    Hatley RH; von Hollen D; Sandell D; Slator L
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27 Suppl 1():S24-36. PubMed ID: 25054480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effect of a holding chamber on the mouth-throat deposition of QVAR (hydrofluoroalkane-beclomethasone dipropionate).
    Rahmatalla MF; Zuberbuhler PC; Lange CF; Finlay WH
    J Aerosol Med; 2002; 15(4):379-85. PubMed ID: 12581504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valved Holding Chambers and In Vitro Metered Dose Inhaler Performance: Effects of Flow Rate and Inhalation Delay.
    Liu X; Guo C; Chowdhury B; Starke P; Limb S; Peri P; Schroeder A; Doub W
    J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):399-410. PubMed ID: 28846482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhalation of tobramycin using simulated cystic fibrosis patient profiles.
    Haynes A; Geller D; Weers J; Ament B; Pavkov R; Malcolmson R; Debonnett L; Mastoridis P; Yadao A; Heuerding S
    Pediatr Pulmonol; 2016 Nov; 51(11):1159-1167. PubMed ID: 27133552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease.
    Kässner F; Hodder R; Bateman ED
    Drugs; 2004; 64(15):1671-82. PubMed ID: 15257628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respimat (a new soft mist inhaler) delivering fenoterol plus ipratropium bromide provides equivalent bronchodilation at half the cumulative dose compared with a conventional metered dose inhaler in asthmatic patients.
    Kunkel G; Magnussen H; Bergmann K; Juergens UR; de Mey C; Freund E; Hinzmann R; Beckers B
    Respiration; 2000; 67(3):306-14. PubMed ID: 10867600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An instrumented valved holding chamber with facemask to measure application forces and flow in young asthmatic children.
    Minh KT; von Hollen D; von Königslöw AJ; Nikander K; Janssens HM
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27 Suppl 1():S55-62. PubMed ID: 25054482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.